ASX Growth Companies With High Insider Ownership In January 2025

In This Article:

As the Australian market continues to navigate the economic landscape shaped by the new Trump administration, the ASX200 has shown resilience, closing up 0.36% at 8,408 points amid positive tariff developments. In this environment of cautious optimism, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the business and may offer potential stability in a fluctuating market.

Top 10 Growth Companies With High Insider Ownership In Australia

Name

Insider Ownership

Earnings Growth

Clinuvel Pharmaceuticals (ASX:CUV)

10.4%

26.2%

SKS Technologies Group (ASX:SKS)

29.7%

24.8%

Medallion Metals (ASX:MM8)

13.8%

67.5%

Acrux (ASX:ACR)

20.2%

91.8%

Brightstar Resources (ASX:BTR)

16.2%

84.1%

Newfield Resources (ASX:NWF)

31.5%

72.1%

AVA Risk Group (ASX:AVA)

15.8%

77.3%

Pointerra (ASX:3DP)

23.8%

126.4%

Plenti Group (ASX:PLT)

12.7%

120.1%

Findi (ASX:FND)

35.8%

110.7%

Click here to see the full list of 89 stocks from our Fast Growing ASX Companies With High Insider Ownership screener.

Below we spotlight a couple of our favorites from our exclusive screener.

Clinuvel Pharmaceuticals

Simply Wall St Growth Rating: ★★★★★★

Overview: Clinuvel Pharmaceuticals Limited is a biopharmaceutical company that develops and commercializes treatments for genetic, metabolic, systemic, and life-threatening disorders across Australia, Europe, the United States, Switzerland, and other international markets with a market cap of A$591.37 million.

Operations: The company's revenue is primarily generated from its Biopharmaceutical Sector, amounting to A$88.18 million.

Insider Ownership: 10.4%

Clinuvel Pharmaceuticals demonstrates strong growth potential with earnings projected to grow 26.17% annually, outpacing the Australian market's 12.6%. Revenue is similarly forecasted to increase by 21.4% per year, surpassing the market's 6.1%. The company trades at a significant discount compared to its estimated fair value and peers, with no substantial insider trading activity reported recently. Recent events include addressing shareholder queries on vitiligo treatments and participating in a healthcare conference.

ASX:CUV Ownership Breakdown as at Jan 2025
ASX:CUV Ownership Breakdown as at Jan 2025

Develop Global

Simply Wall St Growth Rating: ★★★★★★

Overview: Develop Global Limited, along with its subsidiaries, focuses on the exploration and development of mineral resource properties in Australia and has a market cap of A$660 million.